162 related articles for article (PubMed ID: 7587032)
21. [Enterobacter aerogenes pneumopathy treated by a cefepime-sulbactam-gentamicin combination].
Mardrus P; Le Grand JL; Chardon H; Garrigues B
Presse Med; 1998 May 2-9; 27(17):804-5. PubMed ID: 9767884
[TBL] [Abstract][Full Text] [Related]
22. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria.
Kashuba AD; Nafziger AN; Drusano GL; Bertino JS
Antimicrob Agents Chemother; 1999 Mar; 43(3):623-9. PubMed ID: 10049277
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients.
Chaudhary M; Shrivastava SM; Varughese L; Sehgal R
Curr Clin Pharmacol; 2008 May; 3(2):118-22. PubMed ID: 18700304
[TBL] [Abstract][Full Text] [Related]
24. [Guidelines for treatment of pneumonia in intensive care units].
Emmi V
Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
[TBL] [Abstract][Full Text] [Related]
25. The choice of antibacterial drugs.
Med Lett Drugs Ther; 1999 Oct; 41(1064):95-104. PubMed ID: 10548955
[No Abstract] [Full Text] [Related]
26. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
Motaouakkil S; Charra B; Hachimi A; Benslama A
Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
[No Abstract] [Full Text] [Related]
27. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
Simmons BP; Gelfand MS; Grogan J; Craft B
Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
[TBL] [Abstract][Full Text] [Related]
28. Appropriate comparators for alternate dosing strategies.
Tucker H; Wu D
Clin Infect Dis; 2007 Jul; 45(2):269; author reply 269-70. PubMed ID: 17578793
[No Abstract] [Full Text] [Related]
29. Clinical role of cefixime in community-acquired infections.
Chemotherapy; 1998 Sep; 44 Suppl 1():35-8. PubMed ID: 9797423
[No Abstract] [Full Text] [Related]
30. Cefotaxime and metronidazole in severe intra-abdominal infection.
Aprahamian C; Schein M; Wittmann D
Diagn Microbiol Infect Dis; 1995; 22(1-2):183-8. PubMed ID: 7587037
[TBL] [Abstract][Full Text] [Related]
31. Retrospective analysis of the clinical and economic outcomes of twice-daily dosing of cefotaxime in a Canadian tertiary care institution.
Tin LY; Pitre M; Conly JM
Diagn Microbiol Infect Dis; 1995; 22(1-2):135-40. PubMed ID: 7587028
[TBL] [Abstract][Full Text] [Related]
32. Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Yakovlev SV; Stratchounski LS; Woods GL; Adeyi B; McCarroll KA; Ginanni JA; Friedland IR; Wood CA; DiNubile MJ
Eur J Clin Microbiol Infect Dis; 2006 Oct; 25(10):633-41. PubMed ID: 17024505
[TBL] [Abstract][Full Text] [Related]
33. Retrospective analysis of the efficacy of cefotaxime sodium dosed twice daily. The Swedish experience.
Bergquist SO; Eriksson I; Eriksson S; Lönnbro N; Runehagen A; Styrud J; Ahlquist G
Diagn Microbiol Infect Dis; 1995; 22(1-2):163-6. PubMed ID: 7587033
[TBL] [Abstract][Full Text] [Related]
34. Single daily dose of cefodizime in patients with community-acquired pneumonia: an open-label, controlled, randomized study. The Italian Multicentre Community-Acquired Pneumonia Group.
De Palma M; Rocchi D; Canepa G; Peri A; Cantone V
Clin Ther; 1995; 17(3):413-24. PubMed ID: 7585845
[TBL] [Abstract][Full Text] [Related]
35. [Pneumococcal meningitis: a 2-year evaluation of the cefotaxime-vancomycin combination].
Bourrillon A
Presse Med; 1999 Apr; 28(15):819-20. PubMed ID: 10325943
[No Abstract] [Full Text] [Related]
36. [Clinical efficacy of the antimicrobial drug furamag in nosocomial urinary tract infections].
Iakovlev SV; Suvorova MP; Kolendo SE; Burmistrova EN; Sergeeva EV; Cherkasova NA; Eremina LV
Ter Arkh; 2014; 86(10):65-72. PubMed ID: 25509895
[TBL] [Abstract][Full Text] [Related]
37. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
[TBL] [Abstract][Full Text] [Related]
38. A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia.
Petermann W; Alegre-Martin J; Odenholt I; Phillips MJ; Willcox PA; Tack K; Trostmann U; Welling L
Scand J Infect Dis; 2001; 33(11):832-7. PubMed ID: 11760164
[TBL] [Abstract][Full Text] [Related]
39. [Comparative assessment of efficacy of the 3d generation cephalosporins, ceftriabol, and claforan, in patients with community-acquired pneumonia].
Vakhrushev IaM; Starodubtseva OI
Klin Med (Mosk); 2009; 87(7):53-5. PubMed ID: 19705794
[TBL] [Abstract][Full Text] [Related]
40. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Joseph J; Rodvold KA
Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
